Midline Versus Dorsolateral Spinal Cord Stimulation for Post-surgical Neuropathic Pain
NCT ID: NCT06390150
Last Updated: 2025-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
40 participants
INTERVENTIONAL
2025-09-30
2030-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
\- How does DL-SCS compare to traditional SCS and no treatment for treating post-surgical neuropathic pain?
Participants will be asked to
* trial combinations of stimulation across blocks of weeks (randomized cross-over)
* rate their pain after each stimulation trial
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Investigate High-density Spinal Cord Stimulation in Virgin-back Patients
NCT03716973
Placebo Effect In Spinal Cord Electrical Stimulation for Pain
NCT06585033
Treatment With Spinal Cord Stimulation: Effect on Sensory Parameters
NCT01261468
A Prospective Trial for the Effectiveness of the Use of Spinal Cord Stimulation (SCS) in Failed Knee Surgery
NCT01912924
Efficacy of Spinal Cord Stimulation in Patients With a Failed Back Surgery Syndrome.
NCT03462147
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DL-SCS Only
The DL-SCS electrode will be activated with a high-frequency paresthesia-free program.
Spinal Cord Stimulator
The spinal cord stimulator is an implantable pulse generator connected to electrodes with leads that stimulate the spinal cord. The device is programmed to deliver therapeutic stimulation to treat pain.
Stimulation Off
Both electrodes will be programmed for sham stimulation.
Spinal Cord Stimulator
The spinal cord stimulator is an implantable pulse generator connected to electrodes with leads that stimulate the spinal cord. The device is programmed to deliver therapeutic stimulation to treat pain.
M-SCS Only
The M-SCS electrode will be activated with a high-frequency, paresthesia free program.
Spinal Cord Stimulator
The spinal cord stimulator is an implantable pulse generator connected to electrodes with leads that stimulate the spinal cord. The device is programmed to deliver therapeutic stimulation to treat pain.
DL-SCS + M-SCS
Both DL-SCS and M-SCS will be activated with high-frequency, paresthesia free programs.
Spinal Cord Stimulator
The spinal cord stimulator is an implantable pulse generator connected to electrodes with leads that stimulate the spinal cord. The device is programmed to deliver therapeutic stimulation to treat pain.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Spinal Cord Stimulator
The spinal cord stimulator is an implantable pulse generator connected to electrodes with leads that stimulate the spinal cord. The device is programmed to deliver therapeutic stimulation to treat pain.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. A minimum of 50% of pain should be limited to one body part, defined as one limb or one side of trunk.
3. Failed conservative therapies (medication, physiotherapy)
4. Disability more than 6 months
Exclusion Criteria
2. Any underlying condition that would preclude an MRI
3. Untreated psychiatric conditions or substance use disorder
4. Existing medical conditions that would preclude from SCS (history of recurrent infections, uncontrolled cancer, etc.)
5. Surgically treatable lesion (e.g. spinal stenosis, disc herniation)
6. Lack of capacity (e.g. significant cognitive impairment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nova Scotia Health Authority
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lutz Weise
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lutz Weise, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Nova Scotia Health Authority
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Queen Elizabeth Health Science Centre
Halifax, Nova Scotia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MIDL-SCS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.